Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3738studies shown
Showing 1,026-1,050 of 3,738
RecruitingNCT06981598

Prevention of Psychological Health Problems Via Integrated Operational Support

This study is looking at how a digital support tool works for people with Depression, Anxiety, Grief, Leadership, or Dissatisfaction in routine care. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
New York University
Condition
Depression
RecruitingNCT06898788

Probiotic Administration for Adolescent Depression

This study is looking at whether Visbiome can help people with Depression. Participants take part in Visbiome and complete follow-up assessments.

DepressionDrugFrom 15 Years to 24 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
RecruitingNCT06496438

Probiotics for Depression in Cancer Patients

This study is comparing Psychobiotics with placebo for people with depression or anxiety. Participants receive Psychobiotics or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 85 Years
Countries
Greece
Sponsor
Aristotle University Of Thessaloniki
Condition
Depression
RecruitingNCT05908565

Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy

This study is looking at whether Demographic Matching can help people with Depression or Anxiety. Participants take part in Demographic Matching and complete follow-up assessments.

DepressionBehavioralFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
RecruitingNCT07475039

Project HOPEFUL: A PN-RCT With Implementation Science

This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOtherOver 55 Years
Countries
United States
Sponsor
University of Florida
Condition
Depression
RecruitingNCT06814275

Project neuroARTEMIS

This study is comparing ARTEMIS with Waitlist Control (WLC) for people with Stimulant Use, Human Immunodeficiency Virus, or Depression. Participants receive ARTEMIS or Waitlist Control (WLC) and complete study visits and assessments.

DepressionBehavioralFrom 18 Years to 59 Years
Countries
United States
Sponsor
Wake Forest University Health Sciences
Condition
Depression
RecruitingNCT06858189

Promoting Active Therapy: Path to Wellness

This study is comparing Walk-and-talk therapy with Waitlist control for people with depression or anxiety. Participants receive Walk-and-talk therapy or Waitlist control and complete study visits and assessments.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Kansas State University
Condition
Depression
RecruitingNCT07138664

Promoting Mental Health Among At-risk Adolescents in Malaysia

This study is looking at whether questionnaires and follow-up can help people with Depression in Adolescence or Anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionBehavioralFrom 12 Years to 14 Years
Countries
Malaysia
Sponsor
University of Roehampton
Condition
Depression
RecruitingNCT05963308

Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention

This observational study is following people with Depression anxiety, Adjustment Disorders, Adjustment Disorder With Anxious Mood, or Adjustment Disorder With Depressed Mood to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionBehavioralFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Université du Québec a Montréal
Condition
Depression
RecruitingNCT06455293

Psilocybin Therapy for Depression in Parkinson's Disease

This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDrugFrom 40 Years to 80 Years
Countries
United States
Sponsor
Joshua Woolley, MD, PhD
Condition
Depression
RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
RecruitingNCT06378229

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

This study is looking at determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression for people with Treatment Resistant Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDrugOver 18 Years
Countries
Belgium
Sponsor
University Hospital, Ghent
Condition
Depression
RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This study is looking at whether questionnaires and follow-up can help people with Treatment Resistant Depression or Autism Spectrum Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionDrugFrom 21 Years to 80 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
RecruitingNCT07251491

Psilocybin to Treat Depression in Spinal Cord Injury

This study is looking at whether a digital support tool can help people with Spinal Cord Injury, Depression - depression, or Veteran. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherOver 22 Years
Countries
United States
Sponsor
James J. Peters Veterans Affairs Medical Center
Condition
Depression
RecruitingNCT06341426

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

This study is looking at see if one or two doses of psilocybin is more effective in relieving depressive symptoms in patients with treatment-resistant depression (TRD) for people with depression or Treatment-Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University Health Network, Toronto
Condition
Depression
Recruiting | Clinical Trials | HopeStage Research